SPHS
Sophiris Bio, Inc.
SPHS
SPHS
Delisted
SPHS was delisted on the 11th of March, 2020.
31 hedge funds and large institutions have $4.07M invested in Sophiris Bio, Inc. in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
84% less call options, than puts
Call options by funds: $40K | Put options by funds: $248K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
31
Holding in Top 10
–
Calls
$40K
Puts
$248K
Top Buyers
| 1 | +$177K | |
| 2 | +$84K | |
| 3 | +$34.4K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$31.6K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$23K |
Top Sellers
| 1 | -$566K | |
| 2 | -$105K | |
| 3 | -$33K | |
| 4 |
Squarepoint
New York
|
-$12.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.99K |